ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemi... 13/05/2026 Healthcare Drug discovery Innovative drugs In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a... Partners - Oryzon Genomics
Upcoming Webinar: The Art and Science of Cyclic Peptide Drug Design: From Experimental Dis... Del 27/05/2026 to 27/05/2026 Healthcare Drug discovery Innovative drugs International Digitalization
The IIBB-CSIC and Chemotargets promote the development of new therapies against cancer t... 29/04/2026 Healthcare Drug discovery Innovative drugs The agreement combines the preclinical models developed by the Institute of Biomedical Research of Barcelona (IIBB-CSIC)... Partners - Parc Científic de Barcelona
ORYZON to participate in upcoming events in May and June 29/04/2026 Healthcare Drug discovery Innovative drugs Updated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June. Partners - Oryzon Genomics
Webinar: Struggling with early-stage ADC decisions? See how BioDuro teams tackle it Del 06/05/2026 to 06/05/2026 Healthcare Drug discovery
Webinar: Practical Strategies to Advance PROTACs and RIPTACs from Synthesis to In Vitro Pr... Del 30/04/2026 to 30/04/2026 Healthcare Drug discovery
U.S. announces pharmaceutical tariffs under Section 232: what it means for biotech compani... 10/04/2026 Healthcare Drug discovery Rare diseases Innovative drugs Industrial biotechnology International At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for... AseBio
Ysios Capital launches InceptionBio, a €100M fund to drive biotech company creation 27/03/2026 Healthcare Drug discovery InceptionBio is a new €100 million target-size fund focused on biotech company creation and early-stage projects, with a... Partners - Ysios Capital Partners
Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the projec... 24/03/2026 Healthcare Drug discovery Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of 2 million euros. Partners - Parc Científic de Barcelona
ORYZON announces U.S. patent grant covering iadademstat combinations with venetoclax 23/03/2026 Healthcare Drug discovery Innovative drugs Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in... Partners - Oryzon Genomics
